SCHEMBL31468528

SCHEMBL31468528

C=Cc1ccc([Si](CCCN(CCCC)CCCC)(OCC)OCC)cc1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.33
ATP4A P20648 15/20 0.32
ATP4B P51164 15/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31468598 0.90 MAOA (0.32) KCNH2ATP4AATP4B
SCHEMBL31468548 0.88 ATP4A (0.34) KCNH2ATP4AATP4B
SCHEMBL31468493 0.88 KCNH2 (0.33) KCNH2ATP4AATP4B
SCHEMBL31468645 0.86 ALDH1A1 (0.34)
SCHEMBL31468667 0.85 TP53 (0.33)
SCHEMBL31468642 0.80 NR1H2 (0.40) KCNH2ATP4AATP4B
SCHEMBL31468643 0.78 KCNH2 (0.34) KCNH2ATP4AATP4B
SCHEMBL31468590 0.78 MAOA (0.35) KCNH2ATP4AATP4B
SCHEMBL8679101 0.76 ALDH1A1 (0.41)
SCHEMBL31468585 0.76 ALDH1A1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4541800-A1 NITROGEN-CONTAINING SILANE COMPOUND AND METHOD FOR PRODUCING SAME Shin-Etsu Chemical Co., Ltd. (JP) 2025-04-23 EP disclosed
US-20250122230-A1 NITROGEN-CONTAINING SILANE COMPOUND AND METHOD FOR PRODUCING SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250122230-A1 NITROGEN-CONTAINING SILANE COMPOUND AND METHOD FOR PRODUCING SAME HRH3, HRH4, OR10J3 KCNH2 296/4885ATP4A 4245/4885ATP4B 3297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.